Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Solazyme Inc (NASDAQ: SZYM ) fell as much as 10.6% today after the company reported first-quarter earnings.
So what: Revenue was up 85% to $12.4 million but net loss increased from $26.5 million a year ago to $34.7 million last quarter. Even on a non-GAAP basis, the loss of $30.5 million equated to $0.44 per share, which was much higher than the $0.33 loss analysts expected.
Now what: Solazyme has long been a company with a lot of promise, and management pointed to progress in Clinton/Galva, the encapsulated lubricant Encapso, and Algenist. But Solazyme isn't anywhere close to leading to a profit, and analysts have high expectations for the company this year and next. Analysts have estimated revenue of $115.2 million in 2014 and $330.4 million next year, so Solazyme needs to pick up production to keep investors happy, something it clearly didn't do fast enough in the first quarter.
Will this stock be your next multibagger?
The hope was that Solazyme could be a multibagger, but if you give me five minutes I'll show you how you could own the best stock for 2014. Every year, The Motley Fool's chief investment officer hand-picks one stock with outstanding potential. But it's not just any run-of-the-mill company. It's a stock perfectly positioned to cash in on one of the upcoming year's most lucrative trends. Last year his pick skyrocketed 134%. And previous top picks have gained upwards of 908%, 1,252% and 1,303% over the subsequent years! Believe me, you don't want to miss what could be his biggest winner yet! Just click here to download your free copy of "The Motley Fool's Top Stock for 2014" today.